Shaanxi Panlong Pharmaceutical Group Co., Ltd. (SHE:002864)

China · Delayed Price · Currency is CNY

27.05

-0.38 (-1.39%)

Jun 11, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Self-Produced Chinese Patent Medicine	644.11M	644.93M	585.22M	555.50M	508.13M
Self-Produced Chinese Patent Medicine Growth	-0.13%	10.20%	5.35%	9.32%	17.59%
Chinese Herbal Pieces	235.00M	91.27M	23.23M	20.54M	23.76M
Chinese Herbal Pieces Growth	157.46%	292.84%	13.13%	-13.57%	44.66%
Pharmaceutical Commercial Distribution	254.08M	231.27M	365.48M	389.47M	347.30M
Pharmaceutical Commercial Distribution Growth	9.86%	-36.72%	-6.16%	12.14%	58.68%
Health Products	2.14M	960.77K	3.72M	5.45M	4.56M
Health Products Growth	123.16%	-74.17%	-31.77%	19.48%	-
Other	5.53M	5.42M	3.17M	3.34M	-
Other Growth	1.98%	71.07%	-4.95%	-	-
Unallocated Other Business	-	-	-	-	3.73M
Total	1.14B	973.86M	980.83M	974.29M	887.48M
Total Growth	17.15%	-0.71%	0.67%	9.78%	32.40%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	1.14B	973.86M	980.83M	974.29M	887.48M
China Growth	17.15%	-0.71%	0.67%	9.78%	32.40%
Total	1.14B	973.86M	980.83M	974.29M	887.48M
Total Growth	17.15%	-0.71%	0.67%	9.78%	32.40%

Source: S&P Global Market Intelligence.